Women with gynecological disorders such as endometriosis or heavy or irregular periods could be at an elevated risk of heart disease and cerebrovascular disease, researchers report. The findings… read more.
In patients with ACS (acute coronary syndrome) who have undergone DES (drug-eluting stent) implantation, de-escalating DAPT (dual antiplatelet therapy) to ticagrelor monotherapy resulted in a lower risk for… read more.
Researchers report that the risk of death risk from smoking menthol cigarettes is higher than from smoking non-menthol cigarettes, for death from any cause and for death from… read more.
A meta-analysis evaluating bleeding risks among atrial fibrillation (AF) patients treated with therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) indicates that rates of major… read more.
Use of a salt substitute is not only safe but reduces recurrent stroke and saves lives, researchers reported on Feb. 5, 2025 in JAMA Cardiology. “The results suggest… read more.
Researchers report that adjuvant (post-surgical) trastuzumab emtansine (T-DM1) treatment of women with high-risk HER2-positive breast cancer has reduced their long-term risk of death or invasive disease by 46%… read more.
Researchers from a large meta-analysis of relevant studies have reported that the average life expectancy of people with dementia at time of diagnosis ranges from 5.7 years at… read more.
A meta- analysis of studies evaluating the efficacy and safety of various glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for treating obesity in adults without diabetes, suggests… read more.
Researchers report that most treatments for pregnant women with MS (multiple sclerosis) do not lead to increased risks of major adverse outcomes. “We found that most therapies were… read more.
Newly published research suggests an association between COVID-19 infection and accelerated kidney function decline, especially among people who had been hospitalized for the infection. The findings were published… read more.
Atogepant, an oral drug approved to prevent migraine, appears to also alleviate migraine symptoms early after onset has begun. The findings were reported on December 23, 2024 in… read more.
A meta-analysis of data from 14 studies suggests that consumption of coffee and tea is linked to a reduced risk of head and neck cancer, including cancers of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
